Biltmore Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Biltmore Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $352,731 - $395,152	-5,641 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$60.54 - $79.0 $91,294 - $119,132	-1,508 Reduced 21.09%	5,641 $353,000
Q3 2018 Oct 10, 2018	BUY	$71.28 - $78.92 $136,144 - $150,737	1,910 Added 36.46%	7,149 $552,000
Q2 2018 Jul 19, 2018	BUY	$64.88 - $75.68 $194 - $227	3 Added 0.06%	5,239 $371,000
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $17,554 - $21,400	241 Added 4.82%	5,236 $395,000
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $3,130 - $3,674	-44 Reduced 0.87%	4,995 $358,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $363,362 - $430,683	5,039	5,039 $408,000

1,879

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $98.7B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Biltmore Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Biltmore Wealth Management, LLC with notifications on news.